Replies to post #416824 on Amarin Corp Plc (AMRN)

[JRoon71]

RMB/North, I would also suspect that these drugs might become more targeted towards people with severe weight issues, where the risk of side-effects is outweighed by the risk of morbid obesity. I'm not sure that it would make sense to prescribe to someone that wants/needs to lose 20 pounds.

Maybe I'm wrong, but I'm just hoping that the majority of the medical community recognizes this.

At the same time, Vascepa will not see any positive impact from any of this until they begin sales/marketing efforts again, which I don't see happening anytime soon.

[Tatsumaki]

Dr's know this. They tell their patients taking these to increase protein intake and exercise like they do in bariatric surgery or other medically monitored weight loss programs. With O and M selling $$$ Billions a year, absolutely NOBODY cares about "risk of lean tissue loss". Anyone saying that "side effect" might prevent Dr's from prescribing it in a CVD situation with a 400 lb patient is the copest of cope.